Wave Life Sciences (WVE) EBT Margin (2016 - 2025)
Historic EBT Margin for Wave Life Sciences (WVE) over the last 11 years, with Q2 2025 value amounting to 580.17%.
- Wave Life Sciences' EBT Margin fell 4129800.0% to 580.17% in Q2 2025 from the same period last year, while for Sep 2025 it was 682.25%, marking a year-over-year decrease of 4497100.0%. This contributed to the annual value of 89.57% for FY2024, which is 382100.0% down from last year.
- Per Wave Life Sciences' latest filing, its EBT Margin stood at 580.17% for Q2 2025, which was down 4129800.0% from 510.93% recorded in Q1 2025.
- In the past 5 years, Wave Life Sciences' EBT Margin ranged from a high of 13.36% in Q3 2023 and a low of 13685.61% during Q3 2022
- Its 5-year average for EBT Margin is 2372.5%, with a median of 510.93% in 2025.
- In the last 5 years, Wave Life Sciences' EBT Margin plummeted by -136685100bps in 2022 and then skyrocketed by 136989700bps in 2023.
- Wave Life Sciences' EBT Margin (Quarter) stood at 1982.38% in 2021, then plummeted by -75bps to 3472.8% in 2022, then surged by 98bps to 55.95% in 2023, then tumbled by -199bps to 167.19% in 2024, then crashed by -247bps to 580.17% in 2025.
- Its EBT Margin stands at 580.17% for Q2 2025, versus 510.93% for Q1 2025 and 167.19% for Q2 2024.